
MDAI Stock Forecast & Price Target
MDAI Analyst Ratings
Bulls say
Spectral AI is a promising company with a strong focus on utilizing advanced AI algorithms to improve diagnostic capabilities for superficial wounds and burns. With its recent BARDA contract and ongoing development efforts for its DeepView System, the company is well-positioned for growth in the medical technology industry. Additionally, Spectral AI's license model and high margins make it an attractive investment for potential investors.
Bears say
Spectral AI is expected to have lower revenue due to longer clinical and regulatory timelines, setbacks in approvals, and lower uptake of its DeepView System. The company also faces risks such as limited awareness of the technology and delays in regulatory and clinical timelines. Additionally, while the Advanced Wound Care market is large, under-penetrated, and disjointed, MDAI may face competition in its target markets. With limited operating history, it may take some time for the company to establish itself and generate significant revenue.
This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.
MDAI Analyst Forecast & Price Prediction
Start investing in MDAI
Order type
Buy in
Order amount
Est. shares
0 shares